REGULAX

국가: 이스라엘

언어: 영어

출처: Ministry of Health

지금 구매하세요

환자 정보 전단 환자 정보 전단 (PIL)
04-01-2023
공공 평가 보고서 공공 평가 보고서 (PAR)
01-06-2022

유효 성분:

POLYETHYLENE GLYCOL 3350

제공처:

NEOPHARM CONSUMER PRODUCTS LTD, ISRAEL

ATC 코드:

A06AD15

약제 형태:

POWDER FOR ORAL SOLUTION

구성:

POLYETHYLENE GLYCOL 3350 99.973 %W/W

관리 경로:

PER OS

처방전 유형:

Not required

Manufactured by:

BEN SHIMON FLORIS LTD, ISRAEL

치료 그룹:

MACROGOL

치료 영역:

MACROGOL

치료 징후:

Treatment of constipation.

승인 날짜:

2017-04-30

환자 정보 전단

                                PATIENT PACKAGE INSERT IN ACCORDANCE WITH THE PHARMACISTS’
REGULATIONS (PREPARATIONS) – 1986
The medicine is dispensed
without a doctor’s prescription
REGULAX
Powder for preparing an oral solution
ACTIVE INGREDIENT AND ITS CONCENTRATION:
polyethylene glycol 3350, 99.973% w/w.
INACTIVE INGREDIENTS:
See section 6 of this leaflet: “
ADDITIONAL INFORMATION
”.
READ THE ENTIRE LEAFLET CAREFULLY BEFORE YOU START USING THE MEDICINE.
This leaflet contains concise information about the
medicine. If you have further questions, refer to the doctor or
pharmacist.
Use the preparation according to the instructions in the section on
dosage in this leaflet.
If you need further information, consult with the pharmacist. You must
contact a doctor if your symptoms worsen or do not improve.
Regulax does not contain sugar, and is therefore suitable for
diabetics.
1. WHAT IS THE MEDICINE INTENDED FOR?
The medicine is intended for the treatment of constipation. Regulax
softens the stool by increasing the water content in the stool,
and promotes normal bowel activity, thereby relieving constipation.
THERAPEUTIC GROUP:
Osmotic laxative.
2. BEFORE USING THE MEDICINE DO NOT USE THE MEDICINE IF:
• You are sensitive (allergic) to the active ingredient
(polyethylene glycol 3350) or to the additional ingredient (sucralose)
contained
in the medicine.
• You have any intestine or colon disease (such as ulcerative
colitis, Crohn's disease).
•
You have abdominal pain of undetermined cause.
•
You have or suspect a gastrointestinal perforation.
• You have or suspect a bowel obstruction.
SPECIAL WARNINGS REGARDING THE USE OF THIS MEDICINE
BEFORE TREATMENT WITH REGULAX, TELL YOUR DOCTOR IF:
• You have diarrhea and are prone to electrolytic disorders (for
example, if you are elderly, have
impaired hepatic or renal function, or
use diuretics). The doctor will consider monitoring electrolyte level.
• The medicine contains polyethylene glycol (Macrogol). Very few
cases of hypersensitivity reactions (rash, urticaria or edema) have
been
                                
                                전체 문서 읽기
                                
                            

다른 언어로 된 문서

환자 정보 전단 환자 정보 전단 아랍어 04-01-2023
환자 정보 전단 환자 정보 전단 히브리어 04-01-2023

이 제품과 관련된 검색 알림

문서 기록보기